Redefining Immunology
& Inflammation with Precision.
Mirador Therapeutics envisions a bold new era of precision medicine for immune-mediated inflammatory and fibrotic diseases driven by speed and better development accuracy.
Driven by our deep
expertise and passion.
Founded and led by several
& Inflammation with Precision.
Mirador Therapeutics envisions a bold new era of precision medicine for immune-mediated inflammatory and fibrotic diseases driven by speed and better development accuracy.
Driven by our deep
expertise and passion.
Founded and led by several
Location: United States, California, San Diego
Investors 1
Date | Name | Website |
16.09.2024 | ARCH Ventu... | archventur... |
Mentions in press and media 3
Date | Title | Description |
28.09.2024 | ARCH Venture Partners: $3+ Billion New Fund Raised To Invest In Next-Gen Biotech Companies | ARCH Venture Partners announced the closing of ARCH Venture Fund XIII, a venture capital fund with over $3 billion to support the founding and growth of early-stage biotechnology companies. ARCH invests in early-stage companies that prevent... |
25.03.2024 | Mirador Therapeutics Raises Over 400M in Funding | Mirador Therapeutics, Inc., a San Diego, CA-based company advancing multiple therapeutic programs, raised $400m in financing. The round was led by led by ARCH Venture Partners, with early investments from OrbiMed and Fairmount. Other premie... |
- | Mirador Therapeutics | “Mirador – Redefining Immunology & Inflammation with Precision” |